Statistics
Zugriffszahlen seit März 2016. Zugriffszahlen aus dem Vorgängersystem werden nicht mitberücksichtigt.
Total Visits
| Views | |
|---|---|
| Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer | 97 |
Total Visits Per Month
| September 2022 | October 2022 | November 2022 | December 2022 | January 2023 | February 2023 | March 2023 | |
|---|---|---|---|---|---|---|---|
| Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer | 4 | 5 | 1 | 9 | 6 | 3 | 2 |
Top country views
| Views |
|---|
Top cities views
| Views |
|---|